Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

To compare three-drug chemotherapy with cisplatin, doxorubicin, and methotrexate with four-drug chemotherapy with cisplatin, doxorubicin, methotrexate, and ifosfamide for the treatment of osteosarcoma. To determine whether the addition of muramyl tripeptide (MTP) to chemotherapy enhances event-free...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2008-02, Vol.26 (4), p.633-638
Hauptverfasser:	MEYERS, Paul A, SCHWARTZ, Cindy L, KLEINERMAN, Eugenie, LINK, Michael P, NADEL, Helen, NIEDER, Michael, SIEGAL, Gene P, WEINER, Michael A, WELLS, Robert J, WOMER, Richard B, GRIER, Holcombe E, KRAILO, Mark D, HEALEY, John H, BERNSTEIN, Mark L, BETCHER, Donna, FERGUSON, William S, GEBHARDT, Mark C, GOORIN, Alien M, HARRIS, Michael
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Bone Neoplasms - drug therapy Bone Neoplasms - mortality Child Child, Preschool Cisplatin - administration & dosage Disease-Free Survival Diseases of the osteoarticular system Doxorubicin - administration & dosage Female Humans Ifosfamide - administration & dosage Infant Lung Neoplasms - secondary Male Medical sciences Methotrexate - administration & dosage Neoplasm Recurrence, Local Osteosarcoma - drug therapy Osteosarcoma - mortality Osteosarcoma - secondary Survival Rate Tumors Tumors of striated muscle and skeleton
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!